Does conversion of darbepoetin to low doses of CERA maintain hemoglobin levels in non-dialysis chronic kidney disease patients?
In chronic kidney disease patients treated with darbepoetin doses ≤40 μg/week, CERA can be efficaciously used at doses lower than those recommended.
Phcy was not related to FV or FV and beans; this may be attributable to a low intake of these food groups.